Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

MicroRNAs01:22

MicroRNAs

3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

53
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
53
Experimental RNAi02:15

Experimental RNAi

6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Mast-cell derived nerve growth factor drives ILC2 pro-tumoral functions in bladder cancer.

Nature communications·2026
Same author

Single-amino acid variants in target epitopes can confer resistance to antibody-based therapies.

Science translational medicine·2025
Same author

Basic Concepts and Indications of CAR T Cells.

Hamostaseologie·2025
Same author

Selective haematological cancer eradication with preserved haematopoiesis.

Nature·2024
Same author

Melanoma Clonal Heterogeneity Leads to Secondary Resistance after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes.

Cancer immunology research·2024
Same author

TGF-β specifies T<sub>FH</sub> versus T<sub>H</sub>17 cell fates in murine CD4<sup>+</sup> T cells through c-Maf.

Science immunology·2024

相关实验视频

Updated: Jul 17, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.7K

通过利用microRNAs进行细胞治疗.

Marko Hasiuk1, Marianne Dölz1, Romina Marone1

  • 1Department of Biomedicine, Basel University Hospital and University of Basel, Hebelstrasse 20, CH-4031 Basel, Switzerland; Transplantation Immunology & Nephrology, Basel University Hospital, Petersgraben 4, CH-4031 Basel, Switzerland.

Immunology letters
|September 3, 2023
PubMed
概括
此摘要是机器生成的。

工程细胞疗法可以使用microRNAs (miRNAs) 增强,这是基因调节的关键层. 这种方法为开发更复杂,更有效的基于细胞的治疗提供了一个有希望的途径.

关键词:
细胞疗法是一种细胞疗法.没有编码的RNA.合成生物学 合成生物学一个T细胞细胞.miR-17∼92 的使用量.这是一个微型RNA.

更多相关视频

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.7K
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

7.4K

相关实验视频

Last Updated: Jul 17, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.7K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.7K
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

7.4K

科学领域:

  • 生物技术是生物技术.
  • 分子生物学分子生物学
  • 免疫治疗是一种免疫疗法.

背景情况:

  • 自20世纪初以来,细胞疗法已经显著发展,从简单的输血到复杂的仿真抗原受体 (CAR) T细胞.
  • 现代细胞工程利用细胞生物学和分子遗传学的进步来创造可编程的治疗细胞.
  • 虽然蛋白质工程主导着细胞治疗的发展,但非编码RNA,特别是微RNA (miRNA),在转录后基因调节中起着至关重要的作用.

研究的目的:

  • 突出将microRNAs (miRNAs) 纳入工程细胞疗法的潜力.
  • 展示如何利用miRNA来增强治疗细胞的功能和精度.
  • 强调在细胞工程中探索基于非编码RNA的策略的重要性.

主要方法:

  • 审查有关微RNA功能和细胞工程技术的现有文献.
  • 确定miRNAs已成功集成到基于细胞的工程治疗策略中的例子.
  • 分析miRNA结合对细胞行为和治疗结果的影响.

主要成果:

  • 微RNA提供了一个强大的机制,用于微调工程细胞中的基因表达.
  • 成功整合miRNAs可以改善对细胞反应的控制和治疗疗效.
  • 这些例子展示了在先进的细胞疗法中使用miRNA的可行性和好处.

结论:

  • 微RNAs代表了一个有价值的,但尚未充分利用的组件,用于增强工程细胞疗法.
  • 未来的细胞工程工作应该越来越多地考虑miRNAs的战略使用,以实现精确的治疗控制.
  • 利用miRNA介导的基因调节可以推动下一代基于细胞的药物开发的创新.